Bodri, Daniel <br/><br/>
Early ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study.  [electronic resource] 

 -  Fertility and sterility  May 2010 
 - 2418-20 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1556-5653 
<br/><br/><label>Standard No.: </label>10.1016/j.fertnstert.2009.08.036  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Female<br/>Follicle Stimulating Hormone--administration & dosage<br/>Follow-Up Studies<br/>Gonadotropin-Releasing Hormone--administration & dosage<br/>Humans<br/>Luteal Phase--drug effects<br/>Menotropins--administration & dosage<br/>Oocyte Donation--methods<br/>Ovarian Hyperstimulation Syndrome--etiology<br/>Ovulation Induction--methods<br/>Recombinant Proteins--administration & dosage<br/>Risk Factors<br/>Time Factors<br/>Tissue Donors<br/>Young Adult